Saroné Coetzee is a Country Study Lead at Bayer Australia Limited with 17 years of experience in clinical research, site management, and the successful delivery of complex clinical trials across multiple therapeutic areas and both in South Africa and Australia. She drives collaboration between sponsors, research sites, and cross-functional teams to advance patient-focused clinical development programs.
Saroné currently serves as the Country Project Manager for the exPDite-2 clinical trial, an innovative cell therapy study investigating a potential treatment for patients living with Parkinson’s disease. In this role, she leads country-level trial execution, supports site and stakeholder engagement, and helps ensure the successful delivery of this pioneering research program.
Throughout her career, Sarone has developed a strong reputation for operational excellence, strategic stakeholder management, and building high-performing partnerships. She is passionate about strengthening the clinical research ecosystem, improving trial quality and efficiency, and ensuring that patients remain at the centre of every research initiative.
As a respected leader and advocate within the clinical research community, Saroné brings a practical and global perspective to clinical trial delivery, with expertise spanning clinical operations strategy, site management, patient-centric approaches, and the execution of innovative studies that contribute to the development of new therapies for patients worldwide.
Personal Quote:
“Clinical research is more than a process — it’s a commitment to improving lives. Every trial, every patient, and every partnership contribute to the evidence that shapes the future of healthcare.” —